fmeunier

Françoise Meunier, Director General of the European Organisation for Research and Treatment of Cancer, received her medical degree from the Université Libre de Bruxelles (ULB) and completed her research fellowship at the Memorial Sloan-Kettering Cancer Center in New York in 1977-1978 (Fulbright award). She holds a Master’s Degree from the ULB in Medical Oncology (1976) and Internal Medicine, and earned her PhD at the ULB. She is also certified as a Pharmaceutical Medicine specialist by the Faculty of Pharmaceutical Medicine in the United Kingdom as well as in Belgium and has been a Fellow of the Royal College of Physicians of the United Kingdom since 1994. The EORTC is a unique pan-European academic clinical research organisation operating as a non-profit association under Belgian law. Françoise Meunier has led the coordination and administration of all EORTC activities since 1991 with the mandate to promote the EORTC as a major European organisation in the field of oncology with a network of 2,500 oncologists in over 300 universities and a Headquarters staff of 160 representing 17 different nationalities. As Director General, she is responsible for the organisation of scientific activities, public relations and medium-term EORTC strategy as defined by the EORTC Board. Before joining the EORTC in 1991, Françoise Meunier was Head of the Infectious Disease Department at the Institut Jules Bordet in Brussels, Belgium and her personal area of research included mainly Invasive Fungal Infections in Cancer Patients. She has over 150 peer-reviewed published articles and is a member of numerous international oncology scientific societies. Professor Meunier was awarded the Belgian Laureate “Prix Femmes d’Europe 2004-2005”. She is a member of the Belgian Royal Academy of Medicine (Académie Royale de Médecine de Belgique) as of the year 2006. In 2007, she was conferred the honorary title of Baroness by His Royal Majesty King Albert II of Belgium. She received in 2009, the Pezcoller Foundation-ECCO award as a recognition for her unique contribution to oncology and for the dedication of her professional life to the improvement of cancer treatment, care and research. Since 2011, she has been elected Fellow of the European Academy of Cancer Sciences.